4 news items
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
BYSI
3 May 24
innovative cancer therapies, today announced it will host a Research and Development (R&D) Day to discuss the current unmet medical needs
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
BYSI
25 Mar 24
on developing innovative cancer therapies, today announced that the first patient has been dosed in a Phase 2 investigator-initiated trial (IIT
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
AIMD
AISP
ALB
5 Mar 24
.
INNOVATE Corp. (NASDAQ:VATE) rose 24.4% to $0.90
BeyondSpring Regains Compliance With Nasdaq Minimum Bid Price And Periodic Filing Requirements
BYSI
26 Feb 24
innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today announced that on February 20, 2024, the Company
- Prev
- 1
- Next